简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2018-10-23 10:53 Philip Morris International Launches Next Generation of IQOS, the World’s Leading Heated Tobacco Product
2018-10-22 16:20 Outline of New ESMO Guidelines Indicates Inclusion of FOTIVDA®▼ (Tivozanib) for Patients with Advanced Renal Cell Carcinoma
2018-10-22 13:43 Edogawa Niche Prize 2018 to Be Awarded to Prof. James Till for Stem Cell Discovery
2018-10-22 13:40 Investigational Subcutaneous Formulation of Vedolizumab Achieves and Maintains Clinical Remission and Mucosal Healing at Week 52 in Patients with Moderately to Severely Active Ulcerative Colitis
2018-10-22 10:05 PotNetwork Holdings, Inc. Concludes Record Breaking 3rd Quarter with Revenues Exceeding $6.1 Million
2018-10-19 18:27 Real-world study shows using Giotrif®/Gilotrif® (afatinib) followed by osimertinib provides a median of 27.6 months of chemotherapy-free time in patients with EGFR mutation-positive NSCLC
2018-10-19 16:54 Takeda Receives Clearance from the Japan Fair Trade Commission for the Proposed Acquisition of Shire plc
2018-10-18 14:18 Brightree Launches First Patient App for HME
2018-10-17 16:02 AirFit F30, ResMed’s First Minimal-Contact Full Face CPAP Mask, Now Available in the U.S., Canada
2018-10-17 15:08 PotNetwork Holdings, Inc. Releases PCAOB Fully Audited and Reviewed Financial Statements under Its Registration as an SEC Reporting Company
2018-10-17 13:51 Ferring and Evotec Form Strategic Research Alliance in Reproductive Medicine and Women’s Health
2018-10-17 10:21 PotNetwork Holdings, Inc. Files Form 10 To Become SEC Reporting Company
2018-10-16 11:57 HEX Debuts Coin Listing on Singapore Cryptocurrency Exchange BCoin.sg
2018-10-15 15:22 Results from Pradaxa® RE-SPECT ESUS® and RE-SPECT CVT® trials to be presented at the 11th World Stroke Congress
2018-10-12 14:36 Heart Center Dresden to Be First Commercial Clinical Site for Imricor
2018-10-11 16:47 Delos and EDGE Technologies Collaborate to Advance Smart-Healthy Building Management Systems
2018-10-11 11:28 Plant Oil-Extracted Active Ingredient, Blue Oléoactif®, Wins Silver For Hallstar at in-cosmetics Latin America
2018-10-11 10:21 New Analyses from Pivotal Phase 3 Trials of Oral Ozanimod to Be Presented at ECTRIMS 2018
2018-10-11 10:18 New analysis estimates the positive impact of empagliflozin on prolonging life expectancy in adults with type 2 diabetes and established cardiovascular disease
2018-10-11 10:16 Oxford Nanopore Launches MinIT, a Powerful Analysis Device to Enable Real Time, Portable DNA Sequencing